Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy

Phase 2/3 Unknown 60 enrolled Mahidol University Thailand Research Fund · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objectives of this study are to determine efficacy and safety of 0.75% topical capsaicin nanoparticle preparation versus placebo in patient with painful diabetic neuropathy.

Timeline

Start: 2009-09
Primary completion: 2013-10
Completion: 2013-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capsaicin	Small molecule	0.75 %	Topical

Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy

Summary

Timeline

Drugs

Indications